通过F-actin稳定在阿尔茨海默氏病中缓解突触和记忆障碍
Haseena P A1,2, Nimisha Basavaraju1,2, Mahesh Chandran3
1Centre for Brain Research, Indian Institute of Science, Bangalore, Karnataka, 560012, India.
Alzheimer's research & therapy
|September 7, 2024
概括
通过稳定F-actin来恢复突触性actin完整性,可以扭转阿尔茨海默病 (AD) 模型中的记忆缺陷. 这突出了针对突触性动因作为阿尔茨海默氏症认知衰退的潜在治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 突触功能障碍和行为细胞骨损失是阿尔茨海默病 (AD) 的关键特征,有助于认知能力下降.
- 了解突触性动因中的分子变化对于开发AD干预措施至关重要.
研究的目的:
- 在AD小鼠模型 (APP/PS1) 中调查突触性actin互动组变化.
- 探索PSD-95和actin相互作用在突触和认知障碍中的作用.
- 评估在AD中稳定F-actin的治疗潜力.
主要方法:
- 利用质谱法分析了APP/PS1小鼠中的突触性动因相互作用体.
- 在APP/PS1小鼠中使用F-actin稳定剂jasplakinolide.
- 在小鼠模型和人类大脑组织中评估了行为缺陷,突触受体水平和PSD-95-actin关联.
主要成果:
- 在APP/PS1小鼠中观察到减少PSD-95-actin相关性.
- 贾斯普拉基诺利德治疗改善了记忆回忆,恢复了PSD-95-actin关联,并增加了突触F-actin水平.
- 动因稳定增强了突触AMPA/NMDA受体水平和树突脊柱密度,在人类AD组织中发现类似的PSD-95动因破坏.
结论:
- 在临床前和临床模型中,破坏PSD-95actin相互作用与阿尔茨海默病有关.
- 稳定F-actin在恢复突触完整性和改善认知缺陷方面显示出前景.
- 准突触动因子调节是缓解AD认知衰退的潜在治疗途径.
关键词:
亚马帕尔 (AMPAR) 是一个亚马帕尔 (AMPAR).在 APP/PS1 中使用.阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.在F-actin的损失.没有NMDAR,没有NMDAR.在PSD-95中,我们可以看到PSD-95.后突触密度后的突触密度.突触性动因相互作用体的作用.突触功能障碍 突触功能障碍 突触功能障碍更多相关视频
06:44Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
Published on: January 10, 2025
446
04:41Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
23.2K
相关概念视频
Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
Alzheimer's Disease: Overview
454
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
454
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K
Role of Neurotransmitters in Memory
485
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
485
Long-term Potentiation
2.7K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
Hebbian LTP
LTP can occur when...
2.7K
